Our purpose: Pharmacogenomic Tests

For MMJ and Rx Prescription Medications!

The ceo's headshot

My purpose and passion in life is to help as many people as I can.

21 years ago, I started my own Venture Capital business, after serving as a professional President of 5 different companies. Over time I graduated to investments combining healthcare and technology….which has allowed me to help large numbers of people improve their health.

About 4 years ago, I was involved in deep due diligence to acquire a company in the Medical Cannabis industry. I learned about more about the positive results of people successfully utilizing Medical Cannabis to treat undesirable side effects so often created by Rx prescription medications as they also try to reduce their dependencies on prescription drugs.

My daughter-in-law Joy, a biomedical engineer, introduced me to the fantastic evidenced-based science of Pharmacogenomics (PGx).

My own PGx test results indicated I desperately needed to change the one single medication I was taking (for arthritis = old football player!). This test may have saved my life! (or at least my kidney’s!)

Next, we extensively explored the opportunity to use Pharmacogenomic Testing for the major cannabinoids that contribute to the many medical benefits of cannabis. We found that no such test existed! For the past 3 years we have engaged geneticists, researchers, and scientists who have dedicated their lives to Medical Cannabis.

Violâ….a true breakthrough! Our purpose-driven team created Navigator Genomics Testing™ to be the first company to measure your personal genetic metabolism, response and effectiveness for both the most popularly prescribed prescription medications (Rx) and for key cannabinoids used in Medical Cannabis (MMJ)….. Your test results will empower you & your healthcare professionals leading the way for you to receive truly personalized treatments and medications!

With So Many Blessings, the ceo's signature

Our Team

Travis Parr

Founder & CEO

Travis Parr is the Founder of Navigator Genomics™ this unique pharmacogenomics lab testing business that measures one’s individual genes for best utilization choices for Prescription Medications & the key Cannabinoids used for Medical Cannabis.

He is President and Managing Director of Parr Enterprises, LLC, Private Venture Capital, founded in 1995, located in New Orleans, LA and Auburn Hills, MI. Parr Enterprises has a broad and diverse portfolio with emphasis on combining healthcare and innovative technology…… All meant to help as many people as possible with improving their health.

Mr. Parr was an early and active investor in China, providing growth capital to three Chinese companies, leading all three to go public on the NASDAQ, AMEX and Tokyo exchanges.

Formerly, Mr. Parr was lead investor and active participant with the executive team of Corphealth, Inc., an innovative behavioral healthcare company, that grew to a 54,000 physicians’ network serving over 4M people. Corphealth was sold to Humana in 2008.

His other past experiences include: President of Meteor Photo & Imaging Company, the USA’s second largest digital imaging company before selling this company to a UK public company; and as Executive Vice-President of American Tape Company, a $92 million privately-held manufacturer of pressure sensitive tapes and successfully selling the company to a $900M Korean–based conglomerate. Additionally, he served as Executive Vice-President, Allen Test Products, Inc., (artificial intelligence diagnostics software).

He began his career as the Marketing Manager of Chrysler Space Division, New Orleans, LA and was later promoted to Manager of Chrysler’s Electronics Division, Huntsville, AL. He has served as Chairman of the Board for several technology and healthcare businesses.

in 2014 Mr. Parr joined Satori Capital, a Private Equity firm based in Dallas & Fort Worth, as an Operating Partner. Satori’s core values of “Conscious Capitalism and Sustainability” aligned perfectly with Travis’ visions and values.

He is a 29-year member of the Young Presidents’ Organization (YPO) and YPO GOLD, an international organization comprised of 25,000 of the highest-level CEO’s & entrepreneurs around the world. Currently, he serves on the Executive Board, as Mentoring Officer and the Networks’ Officer for YPO Gold Louisiana. Mr. Parr was honored in 2015 as the ‘Network Man of the Year’ by YPO-WPO International.

Mr. Parr was awarded a full athletic scholarship (football) at Vanderbilt University. In 1974, he completed his Bachelor of Arts at Vanderbilt with a double major in Business & East Asian History. He earned an MBA from Emory University in 1977.

Mr. Parr resides in New Orleans, married to his beloved wife Peggy (38 years) and is an active member at Rayne Memorial United Methodist Church and enjoys teaching Sunday School and serving in various leadership roles… and walking their dog named “Gumbeaux”!

Read More

team member profile picture

Jahan Marcu, Ph.D.

Medical Cannabis Science Director

Dr. Marcu received his Doctorate for significant contributions to the study of the structure and function of cannabinoid receptors. Marcu’s published work in the prestigious journal, *Molecular Cancer Therapeutics*, includes studies on the anti-cancer effects of medical cannabinoids. Marcu is an author of the *American Herbal Pharmacopoeia’s Cannabis Inflorescence Monograph*, which has set the current US federal standards of identity, analysis and quality control for cannabis products. 15 years of experience in medical cannabis research, regulations, and advocacy. Dr. Marcu is also the Chief Auditor for Patient Focused Certification; Chief Scientist at Americans for Safe Access; and Co-Founder and R&D Director of Green Standard Diagnostics, Inc. He serves on multiple expert government, trade association committees, and scientific organizations including AHPA, ACS, AOCS, AOAC, ASA, IACM, IMCPC and others. His work has focused on the structure and function of cannabinoid receptors, the anti-cancer properties of cannabis compounds, Lou Gehrig's disease (ALS), as well as method development & validation for analyzing complex formulations. Dr. Marcu was the first recipient of the Billy Martin Research Award from the International Cannabinoid Research Society. He is also a court-qualified synthetic cannabinoid and cannabis expert.

Read More

team member profile picture

Michael Tagen Ph.D

Medical Cannabis & Pharmacology

Mike has a Ph.D. in Pharmacology and Experimental Therapeutics from Tufts University. He has the unique to the medical cannabis industry professional positions and invaluable experiences of working in academia, research, medical and clinical positions and worked in cutting-edge drug development business. Dr. Tagen has been peer-reviewed and published over 65 times, and serves as a frequent lecturer and independent consultant. He has been employed by leading institutions and organizations including Genetech, Bristol Myers Squibb, St. Jude's Research Hospital, and Tufts University. Dr. Tagen has won numerous highly prestigious BioMedical awards.

Read More

team member profile picture

Ivan Echegarrua

Executive Vice President Business Development

Mr. Echegarrua is a proven leader with over 25 years’ experience in acquisitions, disposition, start ups and turn arounds in numerous companies throughout multiply business segments.

As President and CEO of a private equity firm, he lead a team that acquired, managed and ultimately disposed of over 100 million dollars in assets.  -Before that and during the post Katrina era, Mr. Echegarrua’s entrepreneurial spirit drove him to importing building materials from all corners of the world which lead to assisting in reconstruction of more than 10,000 flood damaged structures in the New Orleans area. 

Mr. Echegarrua has an MBA Freeman School of Business at Tulane University attending their Executive Program.


Read More

team member profile picture

Mike Baker

Chief Financial Officer

Mike is the Chief Financial Officer for OnlyYOU®, a CPA and a highly experienced healthcare CFO. Mike started his career with a Big-4 Accounting firm and went on to be CFO in Healthcare and several high growth companies.

At Financial Express, a national franchisor of accounting practices, Baker provided financial leadership as the company grew from three to over sixty franchisees. When he joined Corphealth (aka LifeSynch) a national behavioral services business, gross revenues were $2.7 million. Eighteen years later gross revenues were $200 million. Corphealth was acqiured by Humana and Mike stayed on as CFO and continued the growth and profitability of the company for many more years.

In addition to standard CFO skills and abilities, Baker has a strong expertise in budgeting/forecasting and expense management.

A leader in financial management he has proven success in directing fiscal operations for private and public corporations. Mike has excelled in managing all financial reporting as well as delivering fiscal results to shareholders and boards. Mike has conceived and implemented plans that improve performance of internal teams, elevate profitability, and protect against risk/exposure. Experience includes strategic planning, auditing, due diligence, and private equity portfolio management.

Having worked with start-up companies in the past, Baker quickly recognized and overcome obstacles to profitable growth. He has proven results working with venture capital groups, investors, and investment bankers.

Mike is now a new and very proud grandparent! Mike is a CPA & graduate of University of Texas Arlington.


Read More

team member profile picture

William Perez, JD, MBA, LL.M

Chief Legal Counsel

Billy is Chief Legal Counsel for Navigator Genomics and is currently Managing Director of Audere pllc, a boutique firm that specializes in providing its clients with the highest quality corporate and securities legal and business counsel available. Mr. Perez has over 20 years of experience…ncompassing virtually every aspect of a company’s life cycle, including formation, corporate governance, merger, acquisition, and divestiture planning and structuring, public and private project finance, and day-to-day general contract matters.

Mr. Perez has represented individuals, issuers, institutional investors, investment funds, venture capitalists and angel investors; is adept in managing domestic and cross-border business and transactions; and is proud to be at the forefront of the developing body of law regarding impacting investing.

Billy’s experience includes General Counsel for an international computer hardware manufacturing company and its global subsidiaries and affiliates, co-founder of several companies in diverse fields such as manufacturing, high-tech, food service and retail, and private practice attorney with AmLaw 250 law firms Morgan Lewis & Bockius (Washington, DC), Jones Day (Dallas), Locke Lord (Dallas), and Adams and Reese (New Orleans and Washington, DC).

Billy received his LL.M. in Securities and Financial Regulations from Georgetown Law Center in Washington, DC; J.D. from Loyola University School of Law and MBA from Loyola University, both in New Orleans, Louisiana; and BBA from University of Mississippi in Oxford, Mississippi.

In the community, Billy is passionate about St. Jude Children’s Research Hospital in Memphis, Tennessee, and is a member of St. Jude’s ALSAC Leadership Board.

Billy is also a Vice-Chair of the Board of Directors of Propeller: A Force for Social Change, which tackles tough environmental and societal challenges in the greater New Orleans region through incubating and launching new social ventures. At Propeller, Billy is a founding member of its Social Venture Fund, which is currently launching its initial fund that will make financial investments in social ventures with societal and environmental missions that possess a significant focus on at-risk or underserved communities.

Billy is also a founding Board member of the Paul F. Cressy Foundation, which raises scholarship funds for children of families burdened with a cancer diagnosis.

Billy has been honored several times by New Orleans Magazine as a Top Lawyer in the fields of Mergers and Acquisitions, Securities Regulation, Securities/Capital Markets, and Venture Capital and is licensed to practice law in Louisiana, the District of Columbia, and Virginia.


Read More

team member profile picture

Brian Landry


Brian served as a senior executive in the non-profit healthcare industry for more than 31 years; over 29 years with New Orleans Children’s Hospital and 2 years with its parent corporation LCMC Health, a five hospital not-for-profit large local healthcare system.

He is a devout Catholic and is actively involved with St. Joseph Benedictine Abbey & Seminary College, located in southern Louisiana. Brian has donated his professional advice and counsel for many years and has served as chairman of both the long-range strategic planning committee and the department of institutional advancement. He is chairing a committee that has recently completed and is currently implementing a new business plan for the expanded sales of Abbey caskets. In 2016, Brian was selected the college’s alumnus of the Year.

Brian is a board member and past president of Ronald McDonald House Charities of Southern Louisiana, and also serves on the boards of both the Miracle League of Greater New Orleans and North Shore, which are not-for-profit organizations dedicated to providing the opportunity for kids with special needs to play baseball and other sports in organized leagues.

In early 2016, Brian was invited to join the nine-member board of Patient Services, Inc. (PSI), which is located in Midlothian, Virginia. Founded in 1989, PSI is a 501(c) not-for-profit corporation, which annually provides over $100 million in drug and medical insurance assistance to more than 20,000 patients with rare chronic diseases. PSI has been a pioneer leading the charge to find solutions to the challenges that face the chronically ill in the United States.

During his time at Children’s Hospital, Brian developed personal relationships with hundreds of young patients and their families. Many of these children suffered significantly as a result of their illnesses or injuries, and their parents experienced considerable agony because their children were enduring such pain and suffering, and regrettably, some of these children did not survive. He recognized that many of these children might have suffered significantly less pain and suffering had a test been available to initially identify the most effective drugs for their treatment.

On a very personal note, Brian lost his first wife, Hélène 22 years ago, as the result of an adverse reaction to a chemotherapy drug she received during her treatment for breast cancer. It is because of these reasons that Brian has become emotionally vested in OnlyYou Pharmacogenomics.

Brian plays the trumpet and enjoys golf. He has a daughter, two sons, six grandchildren, and lives in Slidell, LA with his loving wife, Charlotte.


Read More

team member profile picture

Carolyn Smith

Administration & Customer Service

Carolyn loves helping people! Personal experiences, volunteering and advocating throughout her professional life generated a new direction toward the healthcare industry and now to Autism!

In 2014, Carolyn’s position as Director of Marketing and Admissions at the St. Margaret’s Senior Living communities for the skilled and assisted living communities fueled her passion for delivering compassionate and innovative solutions for the aging senior population. In 2015, she completed her certification as a Nursing Assistant to better assist the aging in home population and in 2016, she began working for Home Instead, a national franchise serving seniors at home.




Read More

team member profile picture

Scott Maloney

Technology Strategy

Scott Maloney is the CEO and Co-Founder of BowTie.io, where he’s focused on providing the fastest, most innovative application platform for entrepreneurs. His academic background and business experiences in Genetics has helped shape the mission and goals of our company. BowTie is an early partner of Navigator Genomics™ (“NGT”), assisting with e-commerce platform design, development, and support.

Prior to BowTie.io, Scott led teams and developed strategy for both startups and enterprise ventures, including @Pay, LivingSocial, Human Genome Sciences, and Pfizer. Scott is a geneticist by trade, holding a BS In genetics and cellular biology. Having spent time as an analyst at Pfizer, successfully published several academic papers focused on genetics research, and sold a small genetics bio-tech, he is an asset to assisting with NGT’s strategic direction.

Read More

team member profile picture

Chad Person

Application Development

Chad is the CEO and Creative Director of Bowtie, where he’s leading a revolution in website and application development.

Bowtie is an early partner of OnlyYOU, assisting with platform design, development, and IT support.

Chad has a decade of professional experience in UX, design, product development, digital marketing, and visual communication; having deployed applications, interactive exhibits, and networking sites serving tens of millions of users. He is also an internationally exhibited artist, university lecturer, public speaker, and startup advisor.





Read More